Monday, June 8, 2026

pharma

Biolitec Pharma

Biolitec Pharma is a pharma organization headquartered in GB. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sourc

GB HQ
Public company Type
Company details
Status
Public
HQ
GB
Programs
0
Drugs
0
Patents
25
Intelligence Β· Clinical Trials

Biolitec Pharma clinical trials

0 NCT identifiers linked to Biolitec Pharma programs. 0 trial starts in the last 12 months.

Recent trial activity

  1. Patent grant

    APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.

  2. Patent grant

    APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT

  3. Patent grant

    DIHYDROXY-CHLORINES GLYCO-SUBSTITUΓ‰ES ET CHLORINES BÊTA-FONCTIONNALISΓ‰ES POUR THΓ‰RAPIE ANTIMICROBIENNE PHOTODYNAMIQUE

  4. Patent grant

    GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY

No clinical trials indexed

No NCT identifiers are linked to this company's programs yet.

View clinical projects β†’